GB1209201A - Compositions containing a heart extract - Google Patents
Compositions containing a heart extractInfo
- Publication number
- GB1209201A GB1209201A GB08192/68A GB1819268A GB1209201A GB 1209201 A GB1209201 A GB 1209201A GB 08192/68 A GB08192/68 A GB 08192/68A GB 1819268 A GB1819268 A GB 1819268A GB 1209201 A GB1209201 A GB 1209201A
- Authority
- GB
- United Kingdom
- Prior art keywords
- extract
- heart
- lyophilizing
- april
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 150000003839 salts Chemical class 0.000 abstract 3
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 abstract 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 abstract 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 abstract 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 abstract 1
- 230000001171 adenosinetriphosphoric effect Effects 0.000 abstract 1
- 235000003704 aspartic acid Nutrition 0.000 abstract 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 abstract 1
- 229910001863 barium hydroxide Inorganic materials 0.000 abstract 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 abstract 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 abstract 1
- 239000000920 calcium hydroxide Substances 0.000 abstract 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 abstract 1
- 229910001424 calcium ion Inorganic materials 0.000 abstract 1
- 230000000747 cardiac effect Effects 0.000 abstract 1
- KCIDZIIHRGYJAE-YGFYJFDDSA-L dipotassium;[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate Chemical class [K+].[K+].OC[C@H]1O[C@H](OP([O-])([O-])=O)[C@H](O)[C@@H](O)[C@H]1O KCIDZIIHRGYJAE-YGFYJFDDSA-L 0.000 abstract 1
- 239000000706 filtrate Substances 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 230000008014 freezing Effects 0.000 abstract 1
- 238000007710 freezing Methods 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 230000003472 neutralizing effect Effects 0.000 abstract 1
- 230000010412 perfusion Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 239000002504 physiological saline solution Substances 0.000 abstract 1
- 239000002244 precipitate Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 239000001117 sulphuric acid Substances 0.000 abstract 1
- 235000011149 sulphuric acid Nutrition 0.000 abstract 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 abstract 1
- 229940048102 triphosphoric acid Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Cardiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Vascular Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR102957 | 1967-04-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1209201A true GB1209201A (en) | 1970-10-21 |
Family
ID=8628987
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB08192/68A Expired GB1209201A (en) | 1967-04-17 | 1968-04-17 | Compositions containing a heart extract |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US3691274A (cg-RX-API-DMAC10.html) |
| BE (1) | BE713304A (cg-RX-API-DMAC10.html) |
| DE (1) | DE1767254A1 (cg-RX-API-DMAC10.html) |
| GB (1) | GB1209201A (cg-RX-API-DMAC10.html) |
| LU (1) | LU55859A1 (cg-RX-API-DMAC10.html) |
| NL (1) | NL6805380A (cg-RX-API-DMAC10.html) |
| OA (1) | OA02798A (cg-RX-API-DMAC10.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012091542A1 (en) * | 2010-12-28 | 2012-07-05 | N.V. Nutricia | Combination of components for the prevention and treatment of frailty |
-
1968
- 1968-04-05 BE BE713304D patent/BE713304A/xx unknown
- 1968-04-09 LU LU55859D patent/LU55859A1/xx unknown
- 1968-04-16 US US721879A patent/US3691274A/en not_active Expired - Lifetime
- 1968-04-17 OA OA53257A patent/OA02798A/xx unknown
- 1968-04-17 GB GB08192/68A patent/GB1209201A/en not_active Expired
- 1968-04-17 DE DE19681767254 patent/DE1767254A1/de active Pending
- 1968-04-17 NL NL6805380A patent/NL6805380A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| LU55859A1 (cg-RX-API-DMAC10.html) | 1968-07-03 |
| NL6805380A (cg-RX-API-DMAC10.html) | 1968-10-18 |
| OA02798A (fr) | 1970-12-15 |
| US3691274A (en) | 1972-09-12 |
| BE713304A (cg-RX-API-DMAC10.html) | 1968-08-16 |
| DE1767254A1 (de) | 1972-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2383599T3 (es) | Composición farmacéutica para tratamiento de enfermedades cardiovasculares y cerebrovasculares | |
| Fung et al. | Effect of 15 (R) 15 methylprostaglandin E2 methyl ester on healing of gastric ulcers: controlled endoscopic study | |
| McClure et al. | Time Required for Disappearance of Intradermally Injected Salt Solution: Preliminary Report of Observations, with Special Reference to Cases of Edema | |
| US5985924A (en) | Metastasis suppressory agents | |
| van der Spuy, S., Levy, DW & Levin | Cimetidine in the treatment of herpesvirus infections | |
| EP0270026A3 (en) | Pharmaceutical preparation comprising vitamin b6 | |
| DE58901002D1 (de) | Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken. | |
| Britton et al. | Clinical uses of hyaluronidase: a current review | |
| JPS6016934A (ja) | 抗腫瘍剤 | |
| GB2171302A (en) | Therapeutic hydroxyprolines | |
| Olbe et al. | Effects of gastrin and histamine on vagally induced acid and pepsin secretion in antrectomized dogs | |
| Danese | Pathogenesis of ventricular fibrillation in coronary occlusion: perfusion of coronary arteries with serum | |
| Goldblatt et al. | Studies on Experimental Hypertension: XVII. Experimental Observations on the Treatment of Hypertension | |
| Claps | Two cases of methemoglobinemia and acute hemolytic anemia with death following the ingestion of a solution of para-aminosalicylic acid | |
| Hollenbeck et al. | Actinomycosis treated with sulfadiazine | |
| US4218466A (en) | Method of treating gastric and duodenal ulcers | |
| GB1460325A (en) | Pharmaceutical composition intended for relieving pain and producing analgesia | |
| Gaind et al. | Acute lithium poisoning | |
| Wilkinson | The Anti-Anæmic Principle in Stomach Tissue | |
| Wade | A case of myotonia congenita with hypothyroidism | |
| US3806594A (en) | Method of reducing involuntary movements associated with cerebral palsy using clorazepate dipotassium | |
| Rieber et al. | The absorption of the sodium salt of para-aminosalicylic acid (PAS) from the rectum | |
| GB1030605A (en) | Calcitonin, a blood-calcium reducer | |
| RU2168981C2 (ru) | Способ приготовления лекарственных препаратов | |
| SU573158A1 (ru) | Препарат дл лечени диспепсии тел т |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| 435 | Patent endorsed 'licences of right' on the date specified (sect. 35/1949) | ||
| PCNP | Patent ceased through non-payment of renewal fee |